1. Home
  2. BIAF vs JTAI Comparison

BIAF vs JTAI Comparison

Compare BIAF & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • JTAI
  • Stock Information
  • Founded
  • BIAF 2014
  • JTAI 2018
  • Country
  • BIAF United States
  • JTAI United States
  • Employees
  • BIAF N/A
  • JTAI N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • JTAI Blank Checks
  • Sector
  • BIAF Health Care
  • JTAI Finance
  • Exchange
  • BIAF Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • BIAF 12.2M
  • JTAI 9.9M
  • IPO Year
  • BIAF 2022
  • JTAI N/A
  • Fundamental
  • Price
  • BIAF $0.75
  • JTAI $3.95
  • Analyst Decision
  • BIAF Hold
  • JTAI
  • Analyst Count
  • BIAF 1
  • JTAI 0
  • Target Price
  • BIAF N/A
  • JTAI N/A
  • AVG Volume (30 Days)
  • BIAF 28.2M
  • JTAI 215.0K
  • Earning Date
  • BIAF 05-14-2025
  • JTAI 03-27-2025
  • Dividend Yield
  • BIAF N/A
  • JTAI N/A
  • EPS Growth
  • BIAF N/A
  • JTAI N/A
  • EPS
  • BIAF N/A
  • JTAI N/A
  • Revenue
  • BIAF $9,362,022.00
  • JTAI $14,022,628.00
  • Revenue This Year
  • BIAF $25.19
  • JTAI $16.46
  • Revenue Next Year
  • BIAF $20.00
  • JTAI $193.15
  • P/E Ratio
  • BIAF N/A
  • JTAI N/A
  • Revenue Growth
  • BIAF 269.68
  • JTAI 14.80
  • 52 Week Low
  • BIAF $0.24
  • JTAI $2.30
  • 52 Week High
  • BIAF $3.16
  • JTAI $199.13
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 60.32
  • JTAI 43.35
  • Support Level
  • BIAF $0.24
  • JTAI $3.95
  • Resistance Level
  • BIAF $1.55
  • JTAI $4.41
  • Average True Range (ATR)
  • BIAF 0.13
  • JTAI 0.59
  • MACD
  • BIAF 0.08
  • JTAI -0.10
  • Stochastic Oscillator
  • BIAF 38.64
  • JTAI 6.34

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: